SBI Executes Seven Transactions Devoted to Lower-Limb Technologies

SBI purchased a full suite of fixation devices for small bone reconstruction and repair from Euromedic International Group. The company reports that the products have broad applications in the foot and ankle, as well as the hand and arm. They are currently available only outside of the United States, and SBI plans to bring them into the United States upon completion of what the company hopes will be a rapid regulatory clearance process. The acquired suite also includes a number of prepatent intellectual property filings to expand SBI's lower-limb internal fixation product portfolio. Additionally, key members of the Euromedic team have joined SBI.

SBI acquired significant intellectual property related to a metatarsal implant designed for surgical replacement or resurfacing of the first metatarsophalangeal (MTP) joint. The implant was designed and developed by Shane M. Hollawell, DPM.

SBI acquired significant intellectual property and related assets for the Trihedron MTP hemi implant, designed and developed by Charles Sorbie, MB, ChB, and Gerald Saunders. SBI reports that the implant is uniquely designed with an anatomically shaped stem that complements the SBI SR arthroplasty product line. The device has received 510(k) clearance to be marketed in the United States, and it is also approved in Canada.

SBI has entered into a licensing agreement for the Roto-glide three-part anatomical great toe system, designed and developed by Hakon Kofoed, MD, and Implants International (Cleveland, England).

SBI has entered into a licensing agreement for a unique ankle distraction system using external fixation. The system was designed and developed by S. Robert Rozbruch, MD, director of the Institute for Limb Lengthening and Reconstruction (New York City).

SBI is also licensing a variable-angle, multidimensional locking titanium plate and screw systems technology that was designed and developed by D. F. Wolter and Litos GmbH & Co. KG (Hamburg, Germany). SBI has licensed worldwide rights (with the exception of Germany) for use in the upper limbs, as well as for applications in the ankle, tibia, and fibula of the lower limbs. The company reports that it plans to introduce a variety of products using the technology over the next six to 12 months.

Through a licensing agreement with Therics LLC (Akron, OH), SBI also announced the release of its small-bone void filler product line.